SCHEMBL25906326

SCHEMBL25906326

Cc1cc(O)c(C(C)C)cc1-c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.55
LMNA P02545 3/20 0.50
ESR2 Q92731 1/20 0.50
ALDH1A1 P00352 3/20 0.49
GAA P10253 2/20 0.49
HTT P42858 1/20 0.49
HSD17B10 Q99714 1/20 0.49
MAPT P10636 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
KMT2A Q03164 2/20 0.48
MEN1 O00255 1/20 0.48
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C19 P33261 3/20 0.47
CYP2D6 P10635 2/20 0.47
CYP2C9 P11712 2/20 0.47
ALOX15 P16050 2/20 0.47
HIF1A Q16665 2/20 0.47
BACE1 P56817 1/20 0.47
TP53 P04637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21363250 0.87 HSP90AA1 (0.64) HSP90AA1LMNAESR2ALDH1A1GAA
SCHEMBL21176787 0.86 LMNA (0.50) HSP90AA1LMNAESR2ALDH1A1GAA
SCHEMBL3809486 0.84 LMNA (0.49) HSP90AA1LMNAESR2ALDH1A1GAA
SCHEMBL28122869 0.83 LMNA (0.47) HSP90AA1LMNAALDH1A1GAAHTT
SCHEMBL356688 0.82 LMNA (0.63) HSP90AA1LMNAALDH1A1GAAHTT
SCHEMBL6878813 0.81 BACE1 (0.56) HSP90AA1LMNAESR2ALDH1A1GAA
SCHEMBL26346234 0.81 BACE1 (0.65) LMNAESR2ALDH1A1GAAHTT
SCHEMBL8374411 0.79 ESR2 (0.59) LMNAESR2ALDH1A1GAAHTT
Phenol SCHEMBL691965 0.78 LMNA (0.53) HSP90AA1LMNAALDH1A1GAAHTT
SCHEMBL22312941 0.77 HSP90AA1 (0.50) HSP90AA1LMNAALDH1A1GAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11713335-B2 Aminocoumarin compounds and methods of their use PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2023-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713335-B2 Aminocoumarin compounds and methods of their use AAAS, PROC, AADAC HSP90AA1 1344/4885LMNA 189/4885ESR2 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.